a glycerophospholipid m/z prediction database
Developed by Graeme S.V. McDowell, Alexandre P. Blanchard and Nico Valenzuela
Version 3.2.0
Contact us:
For tech and resource support, please email: lipawrd@uottawa.ca
For scientific comments and inquiries, please email: sbennet@uottawa.ca
For inquiries about neurolipidomic opportunities and the CIHR Training Program in Neurodegenerative Lipidomics, please email: lipidomics@uottawa.ca
NRL and OISB, Dr Steffany Bennett, please email sbennet@uottawa.ca
- Mapping neurodegenerative lipidomes in human and experimental models of disease,
Identifying lipid-protein and lipid-lipid interactions that alter organelle or protein/lipid target function. - High-throughput screening of underlying signaling mechanisms of key lipid species and key regulators of lipid function in simple model systems.
- Characterizing and validating circulating lipid biomarkers in human and experimental models of disease.
- Identifying natural products and their active compounds that act as lipid modulators for strategic intervention.
- Representing and statistically validating lipidomic changes, disseminating and communicating large data sets, developing hybrid biomedical representations and statistical models of neurodegenerative disease.
- Simulating effect of lipid metabolism (computational modelling).
CIMS, Dr Stephen Fai, please email: sfai@cims.carleton.ca
- Representing and statistically validating lipidomic changes, disseminating and communicating large data sets, developing hybrid biomedical representations and statistical models of neurodegenerative disease.
- Simulating effect of lipid metabolism (computational modelling).
Acknowledgements
This resource was developed with the support of the Canadian Institute of Health Research CIHR MOP 89999 (operating) to SALB and DF, STIHR/CIHR Training Program in Neurodegenerative Lipidomics (CPTNL) TGF-96121(trainee support) to SALB, DF, and SF, and the Natural Sciences and Engineering Research Council CREATE to DF and GWS. SF acknowledges the support of CFI and ORF. APB, GSVM recieved CTPNL studentships; SG and NV recieved CTPNL post-professional fellowships; HX and MB received CTPNL post-doctoral fellowships. APB was also supported by Fonds de la recherche en santé du Quebec (FRSQ). HX received a MITACs post-doctoral fellowship. This program uses ChemAxon's Marvin to display the generated chemical structures, Marvin 5.5.1.0, 2011, ChemAxon.